Author:
Uzunoglu Sernaz,Aybatlı Aysun,Kaplan Petek Balkanlı,Cicin Irfan,Sut Necdet,Sayın Cenk,Varol Fusun
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference19 articles.
1. Baker VV. Treatment options for ovarian cancer. Clin Obstet Gynecol. 2001;44:522–30.
2. Partridge EE, Barnes MN. Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin. 1999;49:297–320.
3. Bast RC Jr, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. CA 125: the past and the future. Int J Biol Markers. 1998;13:179–87.
4. Makar AP, Kristensen GB, Kaern J, Børmer OP, Abeler VM, Tropé CG. Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis. Obstet Gynecol. 1992;79:1002–10.
5. Bidart JM, Thuillier F, Augereau C, et al. Kinetics of serum marker concentrations and usefulness in clinical monitoring. Clin Chem. 1999;45:1695–707.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献